Schedule 13G ownership disclosure
TRAVERE THERAPEUTICS INC
Common Shares · CUSIP: 89422G107
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Macquarie Group Limited
Shares: 4,259,557 · Class: 4.9%
- Macquarie Management Holdings Inc
Shares: 4,259,557 · Class: 4.9%
- Macquarie Investment Management Business Trust
Shares: 4,259,557 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-015862
- Form type
- SCHEDULE 13G/A
- Filer
- MACQUARIE GROUP LTD
- CIK
- CIK 1418333
- Filed
- Feb 07, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership